Vascular endothelial growth factor: Angiogenesis, atherogenesis or both? [6]

Journal of the American College of Cardiology

Volumn 38, Issue 7, 2001, Pages 2137-2138

  Dulak, Jozef ^a   Jozkowicz, Alicja ^a   Frick, Matthias ^a   Alber, Hannes F ^a   Dichtl, Wolfgang ^a   Schwarzacher, Severin P ^a   Pachinger, Otmar ^a   Weidinger, Franz ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; MEVINOLIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; STATINE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY ENDOTHELIUM; ATHEROGENESIS; ATHEROSCLEROSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG INDUCED DISEASE; HUMAN; LETTER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PROTEIN SYNTHESIS INHIBITION; RABBIT; RAT; VASCULAR SMOOTH MUSCLE;

ANIMALS; CORONARY ARTERIOSCLEROSIS; CORONARY CIRCULATION; DISEASE PROGRESSION; ENDOTHELIAL GROWTH FACTORS; HUMANS; LYMPHOKINES; MICE; MICE, KNOCKOUT; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035196139     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(01)01623-0     Document Type: Letter

References (9)

1. 165 on progression of atherosclerotic plaque
2. Vascular endothelial growth factor enhances atherosclerotic plaque progression
3. Nitric oxide induces the synthesis of vascular endothelial growth factor by rat vascular smooth muscle cells
4. Genetic augmentation of nitric oxide synthase increases the vascular generation of VEGF
5. VEGF synthesis in vascular smooth muscle cells is enhanced by 7-ketocholesterol and lysophosphatridylcholine independently of their effect on nitric oxide generation
6. Oxidized LDL regulates vascular endothelial growth factor expression in human macrophages and endothelial cells through activation of peroxisome proliferator-activated receptor-γ
7. Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: Possible pathophysiological significance of VEGF in progression of atherosclerosis
8. Immunohistochemical expression of vascular endothelial growth factor/vascular permeability factor in atherosclerotic intimas of human coronary arteries
9. Atorvastatin reduces the blood levels of vascular endothelial growth factor (VEGF) in patients with coronary artery disease